Antimicrobial stewardship: Helping combat the spread of antimicrobial resistance

  13 March 2021

Antibiotics have become the mainstay for fighting bacterial infections in modern medicine, assuring safety in complex procedures such as organ transplants and the treatment of cancer. However, they are not without their consequences: the increased use of antimicrobials means increased risk of resistance in bacteria, fungi, and viruses. Resistance results in reduced effectiveness, leading to reduced antimicrobial benefit for future generations. To ensure that antimicrobials are used scrupulously, antimicrobial stewardship (AMS) programs are on the rise. In this interview, John Hurst, PharmD, BCIDP, Senior Director of Antimicrobial Stewardship for bioMérieux, tells us more about the importance of AMS, current practices, and challenges in the field.

Further reading: Select Science 22
Author(s): Select Science 22
Effective Surveillance   Healthy Patients  
Back

OUR UNDERWRITERS

Unrestricted financial support kindly provided by

Antimicrobial Resistance Fighter Coalition

CDD VAULT Complexity Simplified





Technology Database

Display your AMR Technology, Product and Service

 

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

 

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!